Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm)

Universitaire Ziekenhuizen KU Leuven30 enrolled

Overview

This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Open Angle Glaucoma

Interventions

lasertrabeculoplastyPROCEDURE

Eligibility

Sex: ALLMin age: 18 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: * individuals over 18 years old * willing to sign an informed consent and able to comply the requirements of the study * having no other ocular diseases besides glaucoma Exclusion Criteria: * history of ocular trauma * intraocular surgery (except for phaco) * pigment dispersion and exfoliation glaucoma

Locations (1)

Department of Ophthalmology, UZLeuven

Leuven, Belgium

Outcomes

Primary Outcomes

to compare the intraocular pressure reduction with the micropulse laser trabeculoplasty (532nm) versus the conventional laser trabeculoplasty (532nm)

Time frame: one year of follow-up

Secondary Outcomes

Secondary the complication rate between the two techniques will be compared

Time frame: one year of follow up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.